Table 2.
Factors | Disease-Free Survival | ||
---|---|---|---|
HR | 95% CI | p Value | |
Stage (I/II vs. III) | 0.70 | 0.11–4.5 | 0.71 |
CE | 1.22 | 0.85–1.75 | 0.27 |
DG | 1.00 | 0.98–1.02 | 0.67 |
LysoPC | 1.07 | 0.88–1.32 | 0.45 |
PA | 0.86 | 0.65–1.15 | 0.32 |
PC | 0.99 | 0.97–1.02 | 0.84 |
Plasmenyl-PC | 1.19 | 0.62–2.3 | 0.59 |
Plasmenyl-PE | 0.86 | 0.7–1.06 | 0.18 |
TG | 1.00 | 0.98–1.02 | 0.77 |
CL | 1.04 | 0.98–1.09 | 0.12 |
SB | 0.77 | 0.6–0.98 | 0.03 |
PE | 0.98 | 0.92–1.04 | 0.55 |
PG | 0.93 | 0.8–1.07 | 0.33 |
PI | 1.17 | 0.98–1.4 | 0.06 |
PS | 1.01 | 0.95–1.08 | 0.55 |